MLZ Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Medipharm Labs Corp

Watchlist Manager

Watchlist

Price: 0.0415 EUR -9.78%

Market Cap: €16.8m

M	Medipharm Labs Corp F:MLZ	CA
S	Salesforce Inc XETRA:FOO	US
	Assembly Biosciences Inc F:V7B	US
S	Summit Materials Inc F:7SU	US
D	Daimler Truck Holding AG F:DTG	DE
P	Primoris Services Corp F:1PM	US
F	Fossil Group Inc DUS:FSL	US
E	ePlus inc F:MLE	US
F	First Horizon Corp DUS:FT2	US
I	International Flavors & Fragrances Inc F:IFF	US

Profitability Summary

Medipharm Labs Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

27%

Sustainable 3Y Average Gross Margin

21%

Gross Margin is Increasing

-5% > 27%

Negative Operating Margin

-23%

Negative 3Y Average Operating Margin

-42%

Operating Margin is Increasing

-110% > -23%

Negative Net Margin

-18%

Negative 3Y Average Net Margin

-33%

Net Margin is Increasing

-111% > -18%

Negative Free Cash Flow Margin

-13%

Negative 3Y Average Free Cash Flow Margin

-24%

Free Cash Flow Margin is Increasing

-62% > -13%

Negative ROE

-21%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-35%

ROIC is Increasing

-55% > -30%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

27%

Sustainable 3Y Average Gross Margin

21%

Gross Margin is Increasing

-5% > 27%

Negative Operating Margin

-23%

Negative 3Y Average Operating Margin

-42%

Operating Margin is Increasing

-110% > -23%